Cheilectomy Market Research Report – Forecast till 2027

Cheilectomy Market research report: by method (open, arthroscopic, percutaneous) anesthesia (general, local, and regional anesthesia) medication (prescription pain relievers, NSAIDs) end-users (academic institutes, clinics) – Forecast till 2027

ID: MRFR/Pharma/4024-HCR | February 2021 | Region: Global | 90 pages

Cheilectomy Market Scenario:


Cheilectomy is a surgical procedure aimed to remove the bony lump present on the top of the metatarsophalangeal joint (big toe). Hallux rigidus, a type of big toe arthritis is a major cause of the same. According to a study published in the World Journal of Orthopedics in 2017, hallux rigidus is a degenerative disease of the first MTP joint. Moreover, it is estimated that the disease affects 1 in every 40 people, aged 50 or more. Females are greatly affected by the disease as compared to males, .i.e., by a ratio of 2:1.  Therefore, increasing prevalence of hallux rigidus and growing female population are the major drivers for the market growth during the forecast period. Additionally, increasing demands for minimally invasive procedures and rising healthcare expenditure is estimated to fuel the market. According to the World Health Organization, the geriatric population is projected to grow from an estimated 524 million in 2010 to approximately 1.5 billion by 2050. However, high procedural cost followed by complications like deep vein thrombosis, need for repeated surgery, stiffness in the joints of the toes and low per capita healthcare expenditure in the middle and low-income countries is estimated to restrain the market growth during the projected period. According to the Fairfield Independent Hospital, the procedural cost for the same in 2016 was estimated to be around USD 3,545.


The cheilectomy market is expected to grow at a CAGR of 7.8% during the forecast period.


Intended Audience



  • Pharmaceutical Companies

  • Biotechnological Institutes

  • Government and Private Laboratories

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers


Figure 1:- Global Cheilectomy Market Share, by Region


 Cheilectomy


Sources: WHO, annual reports, press release, white paper, and company presentation


 Segmentation:


The cheilectomy market is segmented by the method, anesthesia, medication, and end-user.


By the method, the cheilectomy market is segmented into open, arthroscopic, and percutaneous method.


By the anesthesia, the cheilectomy market is categorized into general anesthesia, local anesthesia, and regional anesthesia. By the medication, the market is segmented into prescription pain relievers, OCT, and others. By prescription the pain relievers the market is segmented into corticosteroids, opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and others. By the OCT drugs, the market is segmented into ibuprofen, naproxen, and others. By end users, the market is segmented into hospitals & clinics, academic institutes, retail pharmacies, and others.


Regional Analysis:


The Americas dominate the cheilectomy market owing to a well-developed healthcare sector and increasing the prevalence of hallux rigidus. Moreover, increasing healthcare expenditure and presence of the key players within the regions boosts the growth of the market in the Americas. Additionally, increasing geriatric population and growing female population fuels the regional market growth.


Europe is the second largest cheilectomy market, which is followed by Asia Pacific. Osteoarthritis is a common condition that may lead to hallux rigidus. Thus, increasing prevalence of the disease within the region drives the market growth. According to the Arthritis Research U.K in 2013, osteoarthritis was estimated to be the most common musculoskeletal condition in the geriatric population. Additionally, it was estimated that approximately, 8.75 million people within the region had sought some treatment for osteoarthritis.


Asia Pacific is the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies like India & China, and presence of huge opportunity in the market.


On the other hand, the Middle East & Africa has the least share in the cheilectomy market due to the presence of poor economy, especially in the Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.


Research Methodology


 Cheilectomy 1


Sources: WHO, annual reports, press release, white paper, and company presentation


 Key players in cheilectomy market


The key players for the cheilectomy market are Henry Schein, Inc. (U.S.), STEROID S.p.A. (Italy), Pfizer Inc. (U.S.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), Sanofi (France), Janssen Pharmaceuticals, Inc. (Belgium), PurduePharma (U.S.), ALLERGAN (Republic of Ireland), Boehringer Ingelheim International GmbH (Germany), and others.



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   7.8% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Method, Anesthesia, Medication, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Henry Schein, Inc. (U.S.), STEROID S.p.A. (Italy), Pfizer Inc. (U.S.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), Sanofi (France), Janssen Pharmaceuticals, Inc. (Belgium), PurduePharma (U.S.), ALLERGAN (Republic of Ireland), Boehringer Ingelheim International GmbH (Germany), and others
  Key Market Opportunities

  • Increasing demands for minimally invasive procedures
  • Rising healthcare expenditure
  •   Key Market Drivers

  • Increasing prevalence of hallux rigidus
  • Growing female population


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Cheilectomy market is projected to grow at approximately 7.8 % CAGR during the assessment period (2020-2027).

    Increasing prevalence of hallux rigidus among female population and rising demands for minimally invasive procedures are the major tailwinds pushing the growth of the global cheilectomy market.

    High procedural cost and complications such as deep vein thrombosis, need for repeated surgery, and stiffness in the joints of the toes are major growth impeders for the global cheilectomy market.

    North America holds the largest share in the global cheilectomy market, followed by Europe and the Asia Pacific, respectively.

    STEROID S.p.A. (Italy), Henry Schein, Inc. (U.S.), Pfizer Inc. (U.S.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Sanofi (France), PurduePharma (U.S.), Janssen Pharmaceuticals, Inc. (Belgium), ALLERGAN (Republic of Ireland), and Boehringer Ingelheim International GmbH (Germany), are some of the top players operating in the global cheilectomy market.

    TABLE OF CONTENT


    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porters Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Cheilectomy Market, by Method

    6.1 Introduction

    6.2 Open

    Market Estimates & Forecast, 2020 – 2027

    6.3 Arthroscopic

    Market Estimates & Forecast, 2020 – 2027

    6.4 Percutaneous

    Market Estimates & Forecast, 2020 – 2027

    Chapter 7. Global Cheilectomy Market, by Anesthesia

    7.1 Introduction

    7.2 General Anesthesia

    Market Estimates & Forecast, 2020 – 2027

    7.3 Local Anesthesia

    Market Estimates & Forecast, 2020 – 2027

    7.4 Regional Anesthesia

    Market Estimates & Forecast, 2020 – 2027

    7.5 Others

    Chapter 8. Global Cheilectomy Market, by Medication

    8.1 Introduction

    8.2 Prescription Pain Relievers

    Market Estimates & Forecast, 2020 – 2027

    8.2.1 Corticosteroids

    8.2.2 Opioids

    8.2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

    8.2.4 Others

    8.3 OTC Drugs

    Market Estimates & Forecast, 2020 – 2027

    8.3.1 Ibuprofen

    8.3.2 Naproxen

    8.3.3 Others

    Chapter 9 Global Cheilectomy Market, by End User

    9.1 Introduction

    9.2 Hospitals & Clinics

    Market Estimates & Forecast, 2020 – 2027

    9.3 Academic Institutes

    Market Estimates & Forecast, 2020 – 2027

    9.4 Retail Pharmacies

    Market Estimates & Forecast, 2020 – 2027

    9.5 Others

    Chapter 10. Global Cheilectomy Market, by Region

    10.1 Introduction

    10.2 America

    10.2.1 North America

    10.2.1.1 U.S.

    10.2.1.2 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 Italy

    10.3.1.4 Spain

    10.3.1.5 U.K

    10.3.1.6 Rest of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 Republic of Korea

    10.4.6 Rest of Asia Pacific

    10.5 The Middle East & Africa

    10.5.1 United Arab Emirates

    10.5.2 Saudi Arabia

    10.5.3 Oman

    10.5.4 Kuwait

    10.5.5 Qatar

    10.5.6 Rest of the Middle East & Africa

    Chapter 11 Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    11.3.1 Key Developments

    Chapter 12 Company Profiles

    12.1 Henry Schein, Inc.

    12.1.1 Company Overview

    12.1.2 Product Overview

    12.1.3 Financials

    12.1.4 Key Developments

    12.1.5 SWOT Analysis

    12.2 STEROID S.p.A.

    12.2.1 Company Overview

    12.2.2 Product Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.2.5 SWOT Analysis

    12.3 Pfizer Inc.

    12.3.1 Company Overview

    12.3.2 Product Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 Novartis AG

    12.4.1 Company Overview

    12.4.2 Product/Business Segment Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 Abbott

    12.5.1 Company Overview

    12.5.2 Product Overview

    12.5.3 Financial overview

    12.5.4 Key Developments

    12.5.5 SWOT Analysis

    12.6 Merck & Co., Inc.

    12.6.1 Company Overview

    12.6.2 Product Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.6.5 SWOT Analysis

    12.7 Janssen Pharmaceuticals, Inc.

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financials

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    12.8 PurduePharma

    12.8.1 Overview

    12.8.2 Product Overview

    12.8.3 Financials

    12.8.4 Key Developments

    12.8.5 SWOT Analysis

    12.9 ALLERGAN

    12.9.1 Overview

    12.9.2 Product Overview

    12.9.3 Financials

    12.9.4 Key Developments

    12.9.5 SWOT Analysis

    12.10 Boehringer Ingelheim International GmbH

    12.10.1 Overview

    12.10.2 Product Overview

    12.10.3 Financials

    12.10.4 Key Developments

    12.10.5 SWOT Analysis

    12.11 Others

    Chapter 13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s View Point

    13.1.2 Unmet Needs of the Market

    13.2 Key Companies to Watch

    13.3 Prediction of Cheilectomy Industry

    Chapter 14 Appendix

    LIST OF TABLES

    Table 1 Cheilectomy Industry Synopsis, 2020 – 2027

    Table 2 Global Cheilectomy Market Estimates and Forecast, 2020 – 2027, (USD Million)

    Table 3 Global Cheilectomy Market by Region, 2020 – 2027, (USD Million)

    Table 4 Global Cheilectomy Market by Methods, 2020 – 2027, (USD Million)

    Table 5 Global Cheilectomy Market by Anaesthesia, 2020 – 2027, (USD Million)

    Table 6 Global Cheilectomy Market by Medication, 2020 – 2027, (USD Million)

    Table 7 Global Cheilectomy Market by End Users, 2020 – 2027, (USD Million)

    Table 8 North America Cheilectomy Market by Methods, 2020 – 2027, (USD Million)

    Table 9 North America Cheilectomy Market by Anaesthesia, 2020 – 2027, (USD Million)

    Table 10 North America Cheilectomy Market by Medication, 2020 – 2027, (USD Million)

    Table 11 North America Cheilectomy Market by End Users, 2020 – 2027, (USD Million)

    Table 12 U.S. Cheilectomy Market by Methods, 2020 – 2027, (USD Million)

    Table 13 U.S. Cheilectomy Market by Anaesthesia, 2020 – 2027, (USD Million)

    Table 14 U.S. Cheilectomy Market by Medication, 2020 – 2027, (USD Million)

    Table 15 U.S. Cheilectomy Market by End Users, 2020 – 2027, (USD Million)

    Table 16 Canada Cheilectomy Market by Methods, 2020 – 2027, (USD Million)

    Table 17 Canada Cheilectomy Market by, Anaesthesia, 2020 – 2027, (USD Million)

    Table 18 Canada Cheilectomy Market by Medication, 2020 – 2027, (USD Million)

    Table 19 Canada Cheilectomy Market by End Users, 2020 – 2027, (USD Million)

    Table 20 South America Cheilectomy Market by Methods, 2020 – 2027, (USD Million)

    Table 21 South America Cheilectomy Market by, Anaesthesia, 2020 – 2027, (USD Million)

    Table 22 South America Cheilectomy Market by Medication, 2020 – 2027, (USD Million)

    Table 23 South America Cheilectomy Market by End Users, 2020 – 2027, (USD Million)

    Table 24 Europe Cheilectomy Market by Methods, 2020 – 2027, (USD Million)

    Table 25 Europe Cheilectomy Market by, Anaesthesia, 2020 – 2027, (USD Million)

    Table 26 Europe Cheilectomy Market by, Medication, 2020 – 2027, (USD Million)

    Table 27 Europe Cheilectomy Market by, End Users, 2020 – 2027, (USD Million)

    Table 28 Western Europe Cheilectomy Market by, Methods, 2020 – 2027, (USD Million)

    Table 29 Western Europe Cheilectomy Market by, Anaesthesia, 2020 – 2027, (USD Million)

    Table 30 Western Europe Cheilectomy Market by, Medication, 2020 – 2027, (USD Million)

    Table 31 Western Europe Cheilectomy Market by, End Users, 2020 – 2027, (USD Million)

    Table 32 Eastern Europe Cheilectomy Market by, Methods, 2020 – 2027, (USD Million)

    Table 33 Eastern Europe Cheilectomy Market by, Anaesthesia, 2020 – 2027, (USD Million)

    Table 34 Eastern Europe Cheilectomy Market by Medication, 2020 – 2027, (USD Million)

    Table 35 Eastern Europe Cheilectomy Market by End Users, 2020 – 2027, (USD Million)

    Table 36 Asia Pacific Cheilectomy Market by, Methods, 2020 – 2027, (USD Million)

    Table 37 Asia Pacific Cheilectomy Market by, Anaesthesia, 2020 – 2027, (USD Million)

    Table 38 Asia Pacific Cheilectomy Market by Medication, 2020 – 2027, (USD Million)

    Table 39 Asia Pacific Cheilectomy Market by End Users, 2020 – 2027, (USD Million)

    Table 40 Middle East & Africa Cheilectomy Market by Methods, 2020 – 2027, (USD Million)

    Table 41 Middle East & Africa Cheilectomy Market by, Anaesthesia, 2020 – 2027, (USD Million)

    Table 42 Middle East & Africa Cheilectomy Market by Medication, 2020 – 2027, (USD Million)

    Table 43 Middle East & Africa Cheilectomy Market by End Users, 2020 – 2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Cheilectomy Market

    Figure 3 Segmentation Market Dynamics for Global Cheilectomy Market

    Figure 4 Global Cheilectomy Market Share, by Methods, 2020

    Figure 5 Global Cheilectomy Market Share, by Anesthesia, 2020

    Figure 6 Global Cheilectomy Market Share, by Medication 2020

    Figure 7 Global Cheilectomy Market Share, by End Users, 2020

    Figure 8 Global Cheilectomy Market Share, by Region, 2020

    Figure 9 North America Cheilectomy Market Share, by Country, 2020

    Figure 10 Europe Cheilectomy Market Share, by Country, 2020

    Figure 11 Asia Pacific Cheilectomy Market Share, by Country, 2020

    Figure 12 Middle East & Africa Cheilectomy Market Share, by Country, 2020

    Figure 13 Global Cheilectomy Market: Company Share Analysis, 2020 (%)

    Figure 14 Henry Schein, Inc.: Key Financials

    Figure 15 Henry Schein, Inc.: Segmental Revenue

    Figure 16 Henry Schein, Inc.: Geographical Revenue

    Figure 17 STEROID S.p.A.: Key Financials

    Figure 18 STEROID S.p.A.: Segmental Revenue

    Figure 19 STEROID S.p.A.: Geographical Revenue

    Figure 20 Pfizer Inc. : Key Financials

    Figure 21 Pfizer Inc.: Segmental Revenue

    Figure 22 Pfizer Inc.: Geographical Revenue

    Figure 23 Abbott: Key Financials

    Figure 24 Abbott: Segmental Revenue

    Figure 25 Abbot: Geographical Revenue

    Figure 26 Merck & Co., Inc.: Key Financials

    Figure 27 Merck & Co., Inc.: Segmental Revenue

    Figure 28 Merck & Co., Inc.: Geographical Revenue

    Figure 29 Janssen Pharmaceuticals, Inc.: Key Financials

    Figure 30 Janssen Pharmaceuticals, Inc.: Segmental Revenue

    Figure 31 Janssen Pharmaceuticals, Inc.: Geographical Revenue

    Figure 32 Novartis AG: Key Financials

    Figure 33 Novartis AG: Segmental Revenue

    Figure 34 Novartis AG: Geographical Revenue

    Figure 35 PurduePharma: Key Financials

    Figure 36 PurduePharma: Segmental Revenue

    Figure 37 PurduePharma: Geographical Revenue

    Figure 38 ALLERGAN: Key Financials

    Figure 39 ALLERGAN: Segmental Revenue

    Figure 40 ALLERGAN: Geographical Revenue

    Figure 41 Boehringer Ingelheim International GmbH: Key Financials

    Figure 42 Boehringer Ingelheim International GmbH: Segmental Revenue

    Figure 43 Boehringer Ingelheim International GmbH: Geographical Revenue